V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006761 | 10004603 | 1.68 | 67.6 | Palliative (P) | 2015-12-20 | 2015-12-20 | Pemetrexed | 2 | N | 10461098 | NOT MATCHED |
| 10006762 | 10004605 | 1.61 | 65 | Palliative (P) | 2016-12-29 | 2017-01-05 | Azacitidine | N | N | 10461148 | AZACITIDINE |
| 10006763 | 10004606 | 1.74 | 86.65 | Palliative (P) | 2017-12-08 | 2017-12-22 | GemCarbo Days 1+8 | N | N | 10461148 | PEMETREXED |
| 10006764 | 10004607 | 1.55 | 63.1 | Adjuvant (A) | 2017-09-29 | 2017-10-24 | Bendamustine+Rituximab(Sub Courses) | N | N | 10461202 | BENDAMUSTINE + RITUXIMAB |
| 10006765 | 10004608 | null | 77 | Palliative (P) | 2017-12-01 | 2017-12-01 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10461210 | BENDAMUSTINE + RITUXIMAB |
| 10006766 | 10004608 | 1.7 | 92.5 | Palliative (P) | 2018-03-16 | 2018-03-25 | IBRUTINIB | 2 | null | 10461210 | CARBOPLATIN |
| 10006767 | 10004609 | 1.62 | 80.3 | Curative (C) | 2015-06-05 | 2016-04-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10461240 | BENDAMUSTINE + RITUXIMAB |
| 10006768 | 10004610 | 1.69 | 78 | Disease modification (D) | 2016-07-18 | 2016-07-20 | Trial Unspecified | null | null | 10461278 | TRIAL |
| 10006769 | 10004611 | 1.67 | 71.7 | Palliative (P) | 2016-09-06 | 2016-09-07 | BENDAMUSTINE + RITUXIMAB | 2 | null | 10461379 | BENDAMUSTINE + RITUXIMAB |
| 10006770 | 10004612 | 1.6 | 61.4 | Palliative (P) | 2013-12-22 | 2013-12-27 | null | 02 | N | 10461615 | CVP R |
| 10006771 | 10007356 | null | 65.8 | Adjuvant (A) | null | 2017-12-15 | Capecitabine | N | null | 10461642 | CAPECITABINE |
| 10006772 | 10007356 | 1.81 | 90.6 | Palliative (P) | 2018-03-29 | 2018-03-30 | CARBOPLATIN + ETOPOSIDE | N | N | 10461642 | CARBOPLATIN + ETOPOSIDE |
| 10006773 | 10004615 | 1.82 | 0 | Palliative (P) | 2019-04-20 | 2019-05-01 | CARBOPLATIN + ETOPOSIDE | 99 | N | 10461710 | CARBOPLATIN + ETOPOSIDE |
| 10006774 | 10004618 | 1.53 | 63 | Palliative (P) | 2016-08-14 | 2016-09-03 | Carboplatin + Pemetrexed | 2 | N | 10461730 | BCG |
| 10006775 | 10004619 | 0 | 49 | Disease modification (D) | 2017-02-18 | 2017-02-24 | Trial Unspecified | Y | N | 10462477 | TRIAL |
| 10006776 | 10004619 | 1.7 | null | Palliative (P) | 2015-06-26 | 2015-07-23 | Carboplatin + Etoposide iv&po | 02 | N | 10462477 | CARBOPLATIN + ETOPOSIDE |
| 10006777 | 10004621 | 1.9 | 92.7 | Palliative (P) | 2019-08-29 | 2019-09-06 | BCG Intravesical | N | N | 10462600 | CTD |
| 10006778 | 10007358 | 1.7 | 71 | Palliative (P) | 2017-12-07 | 2017-12-10 | Azacitidine | N | N | 10462841 | AZACITIDINE |
| 10006779 | 10004623 | null | 63.5 | Adjuvant (A) | 2017-11-30 | 2017-12-07 | Carboplatin AUC 6 - 10 | 02 | N | 10462879 | BCG |
| 10006780 | 10004624 | 1.95 | 85.5 | Palliative (P) | 2013-09-12 | 2014-03-06 | Fluorouracil + Folinic Acid Weekly | null | null | 10462879 | GEMCITABINE |
| 10006781 | 10004624 | 1.8 | 70.6 | Palliative (P) | 2014-01-05 | 2014-01-12 | Pemetrexed | 2 | N | 10462879 | NOT MATCHED |
| 10006782 | 10009176 | 1.73 | 0 | Palliative (P) | 2015-12-04 | 2015-12-04 | null | N | N | 10463121 | CARBOPLATIN |
| 10006783 | 10004625 | null | 49 | Palliative (P) | 2019-06-27 | 2019-06-28 | Abiraterone | Y | N | 10463272 | NOT MATCHED |
| 10006784 | 10004625 | 1.7 | 74.7 | Palliative (P) | 2015-10-17 | 2015-10-18 | CARBOPLATIN + GEMCITABINE | N | N | 10463272 | CVP R |
| 10006785 | 10004627 | 1.4 | 70.3 | Adjuvant (A) | 2016-01-24 | 2016-01-31 | CARBOPLATIN + PACLITAXEL | N | N | 10463634 | CARBOPLATIN + PACLITAXEL |
| 10006786 | 10004628 | 1.73 | 64.9 | Palliative (P) | 2017-07-14 | 2017-08-06 | Carboplatin + Etoposide iv&po | 2 | N | 10463750 | CARBOPLATIN + ETOPOSIDE |
| 10006787 | 10004629 | null | 84 | Palliative (P) | null | 2016-10-08 | CARBOPLATIN + ETOPOSIDE | 2 | N | 10463860 | CARBOPLATIN + ETOPOSIDE |
| 10006788 | 10004631 | 1.75 | 77 | Palliative (P) | 2016-03-03 | 2016-03-03 | Carboplatin + Vinorelbine Oral | 02 | N | 10463959 | BCG |
| 10006789 | 10004632 | 1.62 | null | Curative (C) | null | 2018-10-26 | R GCVP | N | N | 10464101 | FLUOROURACIL |
| 10006790 | 10004633 | 1.71 | 113.2 | Disease modification (D) | 2018-03-08 | 2018-03-10 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 10464316 | CARBOPLATIN + VINORELBINE |
| 10006791 | 10004634 | 1.55 | 63 | Palliative (P) | 2017-06-18 | 2017-07-01 | CARBOPLATIN + GEMCITABINE | N | null | 10464340 | BCG |
| 10006792 | 10004634 | 1.74 | 92.3 | c | 2016-02-24 | 2016-02-24 | Carboplatin + Vinorelbine IV &PO D8 | 2 | null | 10464340 | BEVACIZUMAB |
| 10006793 | 10004634 | 0 | 115.8 | Curative (C) | 2018-05-23 | 2018-05-30 | Trial Unspecified | 1 | N | 10464340 | TRIAL |
| 10006794 | 10004635 | 1.73 | 56 | Palliative (P) | 2015-10-26 | 2015-10-26 | GEMCARBO | 1 | N | 10464478 | CARBOPLATIN + VINORELBINE |
| 10006795 | 10004636 | 1.63 | 58 | Palliative (P) | 2015-12-19 | 2015-12-26 | CARBOPLATIN + PACLITAXEL | N | N | 10464742 | CARBOPLATIN + PACLITAXEL |
| 10006796 | 10004638 | 1.72 | null | Palliative (P) | 2016-03-06 | 2016-10-10 | Gemcitabine weekly | N | N | 10464747 | PEMETREXED |
| 10006797 | 10004639 | 1.78 | 86 | Palliative (P) | 2014-05-12 | 2014-06-10 | BENDAMUSTINE + RITUXIMAB | N | N | 10464767 | BENDAMUSTINE + RITUXIMAB |
| 10006798 | 10004639 | 1.81 | 87.65 | Curative (C) | 2019-10-24 | 2019-10-28 | CTD | 2 | N | 10464767 | CARBOPLATIN + VINORELBINE |
| 10006799 | 10004640 | 1.66 | 87.2 | Palliative (P) | 2016-10-08 | 2016-10-09 | Azacitidine | 02 | N | 10464862 | AZACITIDINE |
| 10006800 | 10004642 | 1.81 | null | Palliative (P) | null | 2018-07-03 | CARBOPLATIN + VINORELBINE | null | null | 10464952 | FLUOROURACIL |
| 10006801 | 10004643 | null | 88.7 | Curative (C) | 2018-12-10 | 2018-12-22 | Carboplatin + Pemetrexed | Y | N | 10465213 | BCG |
| 10006802 | 10004644 | 1.61 | 94 | Palliative (P) | 2017-12-12 | 2017-12-12 | GemCarbo Days 1+8 | 2 | N | 10465225 | IBRUTINIB |
| 10006803 | 10004645 | 1.76 | 86 | Palliative (P) | 2013-03-05 | 2016-03-28 | GEMCARBO | null | null | 10465525 | GEMCITABINE |
| 10006804 | 10004646 | 1.7 | 115.8 | Palliative (P) | 2017-07-19 | 2017-07-20 | Lenalidomide 25mg (Cycle 1 to 25) | 2 | null | 10465554 | BCG |
| 10006805 | 10004647 | 1.77 | 95.7 | Disease modification (D) | 2017-12-07 | 2017-12-10 | Pemetrexed | N | N | 10465684 | NOT MATCHED |
| 10006806 | 10004648 | 0 | null | Palliative (P) | 2014-06-11 | 2014-06-11 | Capecitabine | 02 | N | 10465732 | CAPECITABINE |
| 10006807 | 10007368 | null | 43.3 | Palliative (P) | 2019-01-04 | 2019-02-03 | Carboplatin + Etoposide iv&po | 02 | N | 10466150 | CARBOPLATIN + ETOPOSIDE |
| 10006808 | 10004654 | 1.67 | 69.6 | Adjuvant (A) | 2017-11-23 | 2018-01-29 | Temozolomide 150mg/m2 | 02 | N | 10466273 | TEMOZOLOMIDE |
| 10006809 | 10004654 | 1.83 | 60 | Adjuvant (A) | 2019-03-20 | 2019-03-24 | Capecitabine | N | N | 10466273 | CAPECITABINE |
| 10006810 | 10004654 | 1.74 | null | Palliative (P) | 2017-06-11 | 2017-06-14 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10466273 | CARBOPLATIN + VINORELBINE |